An indirect comparison of bevacizumab plus cisplatin-gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first-line non-squamous non-small cell lung cancer in East Asia

• المؤلفون الرئيسيون: John Wen Cheng Chang, Sumitra Thongprasert, Elaine Wright, Kenneth Tsang, Heung Tae Kim, Myung Ju Ahn, Joo Hang Kim, Jin Hyoung Kang, Sang We Kim, Stefan Walzer
• التنسيق: دورية
• منشور في: 2018
• الموضوعات: Medicine
• الوصول للمادة أونلاين: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79956069755&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/50230

Aims: To compare the relative efficacy of bevacizumab plus cisplatin-gemcitabine chemotherapy (BevCG) with cisplatin plus pemetrexed (CP) in the first-line treatment of advanced or recurrent non-small cell lung cancer (NSCLC) in East Asian patients. In the absence of evidence from head-to-head trial...